用户名: 密   码:
注册 | 忘记密码?
专利详细信息
专利号
CN103251954A
专利标题 A kind for the treatment of diabetes compound medicine that reduces the rosiglitazone side effect and preparation method thereof
专利权人
发明人
申请号 CN20131189925
申请日 2013/5/22
公开日 2013/8/21
优先权号
IPC A61K04500000;
专利类型
法律状态查询 查看法律状态


The present invention discloses a kind for the treatment of diabetes compound medicine that reduces the rosiglitazone side effect and preparation method thereof belongs to medical preparation field.This compound medicine is made up of rosiglitazone and diuretic and wherein the proportioning of rosiglitazone and diuretic is 1: 0.04~1 by weight.This treatment diabetes compound medicine is by cooperating in spironolactone that can the side effect of fine elimination rosiglitazone amiloride compound recipe amiloride ergosterol triamterene etacrynic acid hydrogen fluorine first thiophene the bumetanide any with the rosiglitazone compound recipe formation had not only reduced the side effect of rosiglitazone but also compound medicine that can fine treatment diabetes.
没有相关的数据
没有相关的数据
引证图片
暂无附图

注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。

上传 | 编辑 | 标注(0) | 下载专利全文 | 收藏